Navigation Links
FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Date:5/28/2009

SpyGlass(R) Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease

NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SpyScope(R) Access and Delivery Catheter for diagnostic and therapeutic applications during endoscopic procedures in the pancreatico-biliary system. The SpyScope Catheter is used in conjunction with the SpyGlass(R) Direct Visualization System. Previously available for use only in the bile and hepatic ducts, the SpyGlass System can now be used to guide visualization and accessory devices throughout the entire pancreatico-biliary system, enabling physicians to diagnose and treat pancreatic cancer or pre-cancerous tissues.

According to the American Cancer Society, in 2008 nearly 38,000 Americans were diagnosed with cancer of the pancreas -- the fourth-leading cause of cancer death in the U.S. Pancreatic cancer is a "silent" disease, with patients often not exhibiting symptoms until late in the disease process. As a result, the majority of patients with late-stage disease have a poor prognosis for survival.

"Early detection is critical to improving outcomes in patients with pancreatic cancer, but the 'silent' nature of the disease -- coupled with the inadequate diagnostic options of traditional x-ray or surgery -- have historically made this very difficult," said Douglas Pleskow, M.D., Beth Israel Deaconess Medical Center, Boston. "The SpyGlass System represents a tremendous advance in both the diagnosis and treatment process of pancreatic disease. With SpyGlass, I can navigate the ducts seamlessly, visualize the areas of interest and deliver treatment. In addition, I can use complementary
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
2. FDA Clears New Applicators for Endometrial Cancer Treatment With Xofts Axxent(R) Electronic Brachytherapy System
3. FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
4. Device That Clears Debris From Artery Aids Blood Flow in PCI
5. FDA Clears Expanded Use of Xofts Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications
6. New filter clears up fiber optic communications
7. FDA Clears Biospace meds Revolutionary Low Dose Xray Imager
8. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
9. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
10. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
11. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
(Date:9/2/2015)... ... September 02, 2015 , ... Advancing ... high-risk surgeries. From vital sign monitoring in ICU to 3D skull printing analysis ... to make real-time clinical decisions with simultaneous access to high precision medical images ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's new $100,000 waste ... energy process and continue to contribute to the sustainability of our natural resources. ... Energy process has been operating at their Mexico facility, Recicladora Temarry, for the ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... science research, today unveiled Genedata Screener ® version 13.0 at ELRIG Drug ... brings to market a rich set of new capabilities. Screener now supports High ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4
... Total Hemoglobin Adhesive ... ... Masimo (Nasdaq:,MASI), the inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion pulse ... (SpHb(TM)) and,oxygen content (SpOC(TM)) monitors, Radical-7 and Rad-87. Masimo also,announced ...
... Inc.,(OTC Bulletin Board: MODG), a biopharmaceutical company applying ... approved,therapeutic proteins, today announced that President Shai Novik ... Conference at 2:00 PM EDT,on September 24, 2008., ... will be webcast live.,It can be accessed at ...
... Barriers and Paves Way ... for Affordable and Efficient Approach, KAKAMEGA, Kenya, Sept. 15 ... was launched today in the Western,Kenyan district of Kakamega in ... care package consisting of a,PermaNet(R) long-lasting insecticide-treated bed net, a ...
Cached Biology Technology:Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors 2Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors 3Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors 4Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease 2Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease 3
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
(Date:8/18/2015)... 2015  Navitas today announced that it ... Submission Content Management webinar scheduled on August ... to the Implementation of Regulatory Submission Standards ... industry, vendors, health authorities, consultants and the ... a standard method of implementing electronic submission ...
(Date:8/12/2015)... CORAL SPRINGS, Florida , August 12, 2015 /PRNewswire/ ... globally, the pace of mobile payment innovation and advanced ... continues to replace the way consumers rely on using ... forges ahead with reinventing the future for payment services ... Inc. (NASDAQ: NXTD ), :  Google, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
... an international public-private consortium to build the most detailed ... completion of three pilot projects and the deposition of ... for use by the research community. In addition, work ... public database containing information from the genomes of 2,500 ...
... diet rich in natural antioxidants improves insulin sensitivity in ... insulin-sensitizing drug metformin, a preliminary study from Italy finds. ... Society,s 92nd Annual Meeting in San Diego. "The ... revealed for the first time one of their biological ...
... PHILADELPHIA - A team of bioengineers from the University ... a computer neural network model to accurately predict how ... a heart attack or stroke. Using an automated, ... of different combinations of biological stimuli like those experienced ...
Cached Biology News:Freely available data supporting next generation of human genetic research 2Freely available data supporting next generation of human genetic research 3Freely available data supporting next generation of human genetic research 4Freely available data supporting next generation of human genetic research 5Freely available data supporting next generation of human genetic research 6Well-defined quantity of antioxidants in diet can improve insulin resistance 2Penn bioengineers create simulator to test blood platelets in virtual heart attacks 2Penn bioengineers create simulator to test blood platelets in virtual heart attacks 3
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, detection range 0.04% to 4%. Procedure: 30 min....
... Mouse monoclonal [APS 26] to Presenilin ... an inherited form of the disease carry ... or the amyloid precursor protein (APP). These ... the longer form of amyloid-beta (main component ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
Biology Products: